Results of the General Meeting LIFE HEALTHCARE GROUP HOLDINGS LIMITED LIFE HEALTHCARE FUNDING LIMITED (Incorporated in the Republic of South Africa) (Incorporated in the Republic of South (Registration number 2003/002733/06) Africa with limited liability) ISIN: ZAE000145892 (Registration number 2016/273566/06) JSE and A2X share code: LHC Bond company code: LHFI (Life Healthcare or the Company and, together with its affiliates, (Life Healthcare Funding) the Group) RESULTS OF THE GENERAL MEETING Capitalised terms not defined in this announcement have the meaning given to such terms in the Terms Announcement and the Circular. 1. INTRODUCTION Shareholders are referred to the Circular distributed on Thursday, 9 November 2023 relating to the proposed disposal of Life Healthcare's interests in Alliance Medical Group to iCON Infrastructure, which incorporated a notice of general meeting of Shareholders to approve the resolution required to authorise and implement the Transaction. 2. RESULTS OF THE GENERAL MEETING Shareholders are hereby advised that pursuant to the General Meeting, held on Friday, 8 December 2023, the ordinary resolution required to authorise and implement the Transaction was approved by the requisite majority of votes. Details of the results of the voting at the General Meeting are set out below: Resolution Votes cast disclosed as Number of Shares voted Shares a percentage in Shares voted disclosed as abstained relation to the total a percentage disclosed as a number of Shares in relation to percentage in voted at the meeting the total relation to the For Against issued total issued Shares* Shares* Ordinary Resolution 100,00% 0.00% 1 201 202 758 81,86% 0,02% Approval of the Transaction in terms of the Listings Requirements * The total number of Shares in issue as at the General Meeting record date was: 1 467 349 162 Shares. 3. CONDITIONS PRECEDENT TO THE TRANSACTION Shareholders and noteholders are further advised that Conditions Precedent, as defined in the Sale and Purchase Agreement and as set out in the Circular, which have been satisfied, include: - Unconditional clearance received for three of the four regulatory conditions precedent as defined under the Regulatory Condition, including merger control clearance in Ireland, Foreign Investment Clearance in Germany, and Foreign Investment Clearance in Italy; - Life Healthcare lender related conditions precedent including the DMTN Guarantee Release Condition and guarantee release conditions for term loan and general banking facilities in South Africa; and - Ordinary resolution in terms of section 9 of the JSE Listings Requirements being approved by Shareholders at the General Meeting of Shareholders. Following the passing of the ordinary resolution by Shareholders, the only regulatory condition precedent to the Transaction outstanding is Foreign Investment Clearance in Austria. The Transaction is still expected to close in the first quarter of 2024. The Company will keep Shareholders and noteholders apprised, and a further announcement will be released on SENS, regarding the fulfilment of the remaining condition precedent and the implementation of the Transaction. Dunkeld 8 December 2023 Sponsor and Debt Sponsor Rand Merchant Bank, a division of FirstRand Bank Limited Date: 08-12-2023 12:30:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.